- Home
- DAO vs OCS Comparison
DAO vs OCS Comparison
Compare DAO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- OCS
- Stock Information
- Founded
- DAO 2006
- OCS 2003
- Country
- DAO China
- OCS Switzerland
- Employees
- DAO N/A
- OCS N/A
- Industry
- DAO Other Consumer Services
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- OCS Health Care
- Exchange
- DAO Nasdaq
- OCS Nasdaq
- Market Cap
- DAO 1.1B
- OCS 1.0B
- IPO Year
- DAO 2019
- OCS N/A
- Fundamental
- Price
- DAO $10.51
- OCS $19.10
- Analyst Decision
- DAO
- OCS Strong Buy
- Analyst Count
- DAO 0
- OCS 4
- Target Price
- DAO N/A
- OCS $41.00
- AVG Volume (30 Days)
- DAO 120.1K
- OCS 114.1K
- Earning Date
- DAO 11-13-2025
- OCS 11-06-2025
- Dividend Yield
- DAO N/A
- OCS N/A
- EPS Growth
- DAO N/A
- OCS N/A
- EPS
- DAO 0.27
- OCS N/A
- Revenue
- DAO $785,636,394.00
- OCS $960,668.00
- Revenue This Year
- DAO $5.78
- OCS $38.85
- Revenue Next Year
- DAO $13.12
- OCS $994.06
- P/E Ratio
- DAO $39.44
- OCS N/A
- Revenue Growth
- DAO N/A
- OCS N/A
- 52 Week Low
- DAO $4.54
- OCS $14.00
- 52 Week High
- DAO $11.82
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- DAO 48.23
- OCS 42.25
- Support Level
- DAO $10.37
- OCS $19.00
- Resistance Level
- DAO $10.80
- OCS $21.98
- Average True Range (ATR)
- DAO 0.52
- OCS 0.76
- MACD
- DAO -0.13
- OCS -0.38
- Stochastic Oscillator
- DAO 22.30
- OCS 4.00
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.